ultrasound-guided continuous sciatic block with longitudinal approach
Procedureultrasound-guided continuous sciatic block with longitudinal approach
NCT Number: NCT04278014
Critical limb ischemia (CLI) is associated with severe pain that is a therapeutic challenge whit therapeutic limits for the use of conventional analgesics medications. ultrasound-guided continuous sciatic block (CCBN) is strategy effective and safe to consider in this patients.
This prospective descriptive exploratory cohort study evaluates CCBN as a effective therapeutic tools for patients whit (CLI)
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
hospital universitario San Vicente Fundacion, Medellín, Antioquia, Colombia
Critical limb ischemia is the final stage of peripheral vascular disease identified by resting pain greater than 2 weeks with ulcers or gangrene in 1 or both extremities. Pain relief is a therapeutic challenge due to its severity, which significantly affects the quality of life, and the comorbidities that occur frequently in these patients, which limits the use of analgesics medications. Regional techniques can play an important role as they are safe and effective in analgesic management . Within these we find the ultrasound guided continuous sciatic block as a strategy to consider in the periods of exacerbation of pain, as a bridge to a palliative or resolutive management.
Prospective descriptive exploratory cohort study.
Patients with a diagnosis of critical ischemia of the lower limb with severe pain and side effects of opioids will be included. A continuous ultrasound-guided sciatic nerve block with longitudinal approach will be performed, with no anti-aggregation or anticoagulation suspension, continuing with an infusion of Bupivacaine 0.1%
The primary outcome will be numerical pain rating scale (NPrs) and secondary outcome Pinprick test, catheter duration, opioid consumption reduction and side effects to it.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
ultrasound-guided continuous sciatic block with longitudinal approach
Time frame: 5 days
0-10 where 0 means no pain and 10 means maximum possible pain
Time frame: 5 days
evaluation of superficial sensitivity in S1 dermatome positive or negative
Time frame: 5 days
number of days in which the catheter is functional
Time frame: 5 days
opioid consumption in morphine equivalence
Time frame: 5 days
minimental test score from 0 to 30 points. Delirium positive for less than 24
Time frame: 5 days
yes or not present
Universidad de Antioquia
Other
Evaluation of Ultrasound Guided Continuous Sciatic Block Nerve With a Longitudinal Approach in the Management of Vascular Pain in Critical Ischemia of Lower Limbs Patients : Prospective Descriptive Study of Exploratory Cohort
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05358353
Arterial Occlusive Diseases, Arteriosclerosis
Jonesboro, Arkansas, United States
View Trial DetailsNCT07383064
Arterial Occlusive Diseases, Arteriosclerosis
Aswān, Aswan Governorate, Egypt
View Trial DetailsNCT03807661
Arterial Occlusive Diseases, Arteriosclerosis
Bristol, United Kingdom
View Trial DetailsNCT03321552
Arterial Occlusive Diseases, Arteriosclerosis
Graz, Austria
View Trial Details